Alnylam Pharmaceuticals
$231.66
$231.66
-$0.34 (-0.15%) As of 5:15 PM UTC today
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO.
CEOYvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees1,665
Employees1,665
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2002
Founded2002
Employees1,665
Employees1,665
ALNY Key Statistics
Market cap27.81B
Market cap27.81B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.96M
Average volume1.96M
High today$234.51
High today$234.51
Low today$228.08
Low today$228.08
Open price$231.90
Open price$231.90
Volume415.18K
Volume415.18K
52 Week high$234.51
52 Week high$234.51
52 Week low$117.58
52 Week low$117.58
Analyst ratings
62%
of 26 ratingsBuy
61.5%
Hold
34.6%
Sell
3.8%
ALNY Earnings
-$2.03
-$1.79
-$1.54
-$1.30
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated-$1.62 per share
Estimated-$1.62 per share
Actual-$2.03 per share
Actual-$2.03 per share